We are live on ! Find out more
PETS icon

PetMed Express

59 hedge funds and large institutions have $17.6M invested in PetMed Express in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.9% less ownership

Funds ownership: 35.71%33.81% (-1.9%)

8% less funds holding

Funds holding: 6459 (-5)

28% less capital invested

Capital invested by funds: $24.6M → $17.6M (-$6.99M)

38% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 24

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

67% less call options, than puts

Call options by funds: $87K | Put options by funds: $265K

Holders
59
Holders Change
-5
Holders Change %
-7.81%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
15
Reduced
24
Closed
10
Calls
$87K
Puts
$265K
Net Calls
-$178K
Net Calls Change
-$596K
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$3.19M -$15.2K -4,900 -0.4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.42M
Hotchkis & Wiley Capital Management
3
Hotchkis & Wiley Capital Management
California
$1.98M -$120K -38,800 -5%
BlackRock
4
BlackRock
New York
$1.36M -$6.35K -2,053 -0.4%
Federated Hermes
5
Federated Hermes
Pennsylvania
$1.21M +$2.94K +952 +0.2%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$1.21M +$76.2K +24,624 +5%
OCMI
7
Oaktop Capital Management II
New Jersey
$1.09M
Geode Capital Management
8
Geode Capital Management
Massachusetts
$511K -$48.4K -15,636 -7%
Citadel Advisors
9
Citadel Advisors
Florida
$457K +$161K +51,984 +40%
Arrowstreet Capital
10
Arrowstreet Capital
Massachusetts
$440K -$220K -71,197 -29%
Man Group
11
Man Group
United Kingdom
$379K +$30.9K +9,989 +7%
FAM
12
Formidable Asset Management
Ohio
$329K -$48.6K -15,700 -14%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$302K
THC
14
Truffle Hound Capital
Maryland
$301K
BCM
15
Bridgeway Capital Management
Texas
$271K +$207K +67,016 +164%
Ameriprise
16
Ameriprise
Minnesota
$261K -$120K -38,800 -27%
State Street
17
State Street
Massachusetts
$245K -$5.26K -1,700 -2%
UBS Group
18
UBS Group
Switzerland
$216K +$26.9K +8,700 +11%
Northern Trust
19
Northern Trust
Illinois
$154K -$22.9K -7,394 -11%
EF
20
Empowered Funds
Pennsylvania
$151K +$124K +40,116 +201%
American Century Companies
21
American Century Companies
Missouri
$150K
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$99K -$143K -46,363 -54%
Invesco
23
Invesco
Georgia
$90.6K -$114K -37,005 -51%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$87.1K +$56.8K +18,370 +112%
CIBC Private Wealth Group
25
CIBC Private Wealth Group
Georgia
$75.3K +$92.8K +30,000 New

PETS Hedge Fund Activity: Q3 2025 in Review

59 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in PetMed Express (PETS) for Q3 2025, worth a combined $17.6M — down 28% from $24.6M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of PETS and 5 opened new positions — a net loss of 5 holders — while 24 trimmed existing stakes and 15 added.

The largest buyer was Bridgeway Capital Management, adding an estimated $207K. The largest seller was Invenomic Capital Management, exiting entirely with an estimated $325K sold.

  • 59 institutional investors held PetMed Express (PETS) as of Q3 2025, down from 64 in Q2 2025.
  • Funds reported $17.6M of PetMed Express stock for Q3 2025, down 28% quarter-over-quarter.
  • 5 funds opened new PetMed Express positions in Q3 2025 and 10 closed out, a net change of -5 holders.
  • The largest PetMed Express buyer in Q3 2025 was Bridgeway Capital Management, an estimated $207K added.
  • The largest PetMed Express seller in Q3 2025 was Invenomic Capital Management, an estimated $325K sold.

Based on aggregated 13F filings for Q3 2025.